Stocks
Fate Therapeutics (FATE) P/FCF US GAAP (year values) |
|||||||||
| 2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
| P/FCF | -14.7 | -169.6 | -26.0 | -3.44 | -2.66 | -1.96 | |||
| Changes by years, y/y, % | -16% | +1 051% | -85% | -87% | -23% | -31.5% | |||
Fate Therapeutics. P/FCF
Fate Therapeutics. P/FCF, changes, %
Fate Therapeutics (FATE) P/FCF US GAAP (quarter values) |
||||||||
| 2023Q3 | 2023Q4 | 2024Q1 | 2024Q2 | 2024Q3 | LTM ? | |||
| P/FCF | -1.14 | -2.66 | -5.31 | -2.72 | -3.11 | -1.96 | ||
| Changes by years, y/y, % | -85% | -23% | +129% | +21% | +173% | |||
| Changes by quarters, q/q, % | -49% | +134% | +99% | -49% | +14% | |||
